Literature DB >> 12834570

Therapies for Preventing Heart Failure.

Richard F. Wright1.   

Abstract

Heart failure is an increasingly common syndrome. Despite numerous advances in the treatment of patients with established heart failure, the prevalence and economic burden of the disease will continue to escalate as long as the number of patients with heart failure continues to increase. Much effort has been directed at developing and refining expensive therapies for the small number of patients with advanced heart failure; these efforts will offer little benefit to public health. Simple preventive strategies have been shown to reduce the likelihood of heart failure. Widespread use of these strategies would result in substantial improvement in community health and reduction in societal cost for a disease that will otherwise prove increasingly burdensome.

Entities:  

Year:  2003        PMID: 12834570     DOI: 10.1007/s11936-003-0032-x

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  50 in total

Review 1.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease.

Authors:  Edward G Lakatta; Daniel Levy
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population.

Authors:  T A McDonagh; C E Morrison; A Lawrence; I Ford; H Tunstall-Pedoe; J J McMurray; H J Dargie
Journal:  Lancet       Date:  1997-09-20       Impact factor: 79.321

4.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

5.  Epidemiology of heart failure in the United States.

Authors:  R F Gillum
Journal:  Am Heart J       Date:  1993-10       Impact factor: 4.749

6.  Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.

Authors:  J He; L G Ogden; L A Bazzano; S Vupputuri; C Loria; P K Whelton
Journal:  Arch Intern Med       Date:  2001-04-09

7.  Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study.

Authors:  D W Kitzman; J M Gardin; J S Gottdiener; A Arnold; R Boineau; G Aurigemma; E K Marino; M Lyles; M Cushman; P L Enright
Journal:  Am J Cardiol       Date:  2001-02-15       Impact factor: 2.778

8.  Survival of patients with a new diagnosis of heart failure: a population based study.

Authors:  M R Cowie; D A Wood; A J Coats; S G Thompson; V Suresh; P A Poole-Wilson; G C Sutton
Journal:  Heart       Date:  2000-05       Impact factor: 5.994

9.  Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients.

Authors:  Daniel L Dries; Mark H Strong; Richard S Cooper; Mark H Drazner
Journal:  J Am Coll Cardiol       Date:  2002-07-17       Impact factor: 24.094

10.  Clinical epidemiology of heart failure.

Authors:  L Tavazzi; C Opasich
Journal:  Congest Heart Fail       Date:  1999 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.